Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer.

Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer. Cancer Manag Res. 2009 Nov 03; 1:151-4.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.